Atalanta Sosnoff Capital LLC lessened its position in Aetna Inc (NYSE:AET) by 96.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 13,384 shares of the company’s stock after selling 344,536 shares during the quarter. Atalanta Sosnoff Capital LLC’s holdings in Aetna were worth $2,414,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the company. Capital World Investors increased its stake in Aetna by 8.9% in the 2nd quarter. Capital World Investors now owns 20,769,004 shares of the company’s stock worth $3,153,358,000 after buying an additional 1,688,767 shares during the period. FMR LLC increased its stake in Aetna by 73.8% in the 2nd quarter. FMR LLC now owns 13,736,800 shares of the company’s stock worth $2,085,659,000 after buying an additional 5,833,567 shares during the period. Janus Henderson Group PLC increased its stake in Aetna by 1.8% in the 3rd quarter. Janus Henderson Group PLC now owns 4,407,172 shares of the company’s stock worth $700,784,000 after buying an additional 78,272 shares during the period. UBS Asset Management Americas Inc. increased its stake in Aetna by 7.5% in the 2nd quarter. UBS Asset Management Americas Inc. now owns 2,553,496 shares of the company’s stock worth $387,697,000 after buying an additional 177,364 shares during the period. Finally, Fred Alger Management Inc. increased its stake in Aetna by 18.4% in the 2nd quarter. Fred Alger Management Inc. now owns 1,661,780 shares of the company’s stock worth $252,308,000 after buying an additional 257,678 shares during the period. Hedge funds and other institutional investors own 87.80% of the company’s stock.

Several research analysts recently commented on the stock. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $175.00 price target on shares of Aetna in a research note on Monday, October 23rd. Citigroup raised their target price on shares of Aetna from $183.00 to $197.00 and gave the company a “buy” rating in a research report on Thursday, November 2nd. Zacks Investment Research downgraded shares of Aetna from a “buy” rating to a “hold” rating in a research report on Tuesday, October 3rd. Argus reissued a “buy” rating and set a $185.00 target price (up previously from $165.00) on shares of Aetna in a research report on Tuesday, September 12th. Finally, BMO Capital Markets raised their target price on shares of Aetna from $175.00 to $200.00 and gave the company a “market perform” rating in a research report on Friday, October 27th. Twelve investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $172.64.

Aetna Inc (NYSE AET) traded down $1.05 during trading hours on Tuesday, hitting $183.60. 3,756,594 shares of the stock were exchanged, compared to its average volume of 3,012,566. Aetna Inc has a twelve month low of $116.04 and a twelve month high of $192.37. The company has a market cap of $59,870.00, a PE ratio of 33.94, a P/E/G ratio of 1.64 and a beta of 0.61. The company has a quick ratio of 0.53, a current ratio of 0.53 and a debt-to-equity ratio of 0.52.

Aetna (NYSE:AET) last released its quarterly earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share for the quarter, beating analysts’ consensus estimates of $2.06 by $0.39. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The business had revenue of $14.99 billion for the quarter, compared to analysts’ expectations of $15.12 billion. During the same period last year, the business earned $2.07 EPS. The company’s revenue was down 5.0% compared to the same quarter last year. equities analysts expect that Aetna Inc will post 9.78 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Thursday, January 11th will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.09%. The ex-dividend date of this dividend is Wednesday, January 10th. Aetna’s dividend payout ratio is currently 36.97%.

TRADEMARK VIOLATION WARNING: This news story was originally posted by Watch List News and is owned by of Watch List News. If you are reading this news story on another domain, it was illegally copied and republished in violation of U.S. & international trademark and copyright law. The legal version of this news story can be accessed at https://www.watchlistnews.com/atalanta-sosnoff-capital-llc-has-2-41-million-stake-in-aetna-inc-aet/1800236.html.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with Analyst Ratings Network's FREE daily email newsletter.